Salomon & Ludwin’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8K Sell
151
-102
-40% -$44.6K 0.01% 460
2026
Q1
$114K Buy
253
+28
+12% +$14.2K 0.01% 223
2025
Q4
$127K Buy
225
+35
+18% +$18.6K 0.01% 201
2025
Q3
$85.9K Buy
190
+147
+342% +$70.5K 0.01% 257
2025
Q2
$23.2K Sell
43
-2
-4% -$1.05K ﹤0.01% 364
2025
Q1
$22.3K Hold
45
﹤0.01% 348
2024
Q4
$23.5K Sell
45
-2
-4% -$1.04K ﹤0.01% 331
2024
Q3
$23.1K Sell
47
-2
-4% -$931 ﹤0.01% 350
2024
Q2
$21.8K Sell
49
-2
-4% -$797 ﹤0.01% 354
2024
Q1
$20.4K Sell
51
-9
-15% -$3.4K ﹤0.01% 465
2023
Q4
$17.5K Hold
60
﹤0.01% 431
2023
Q3
$17.5K Buy
+60
New +$18.7K ﹤0.01% 430
2020
Q2
Sell
-75
Closed -$12K 140
2020
Q1
$12K Hold
75
﹤0.01% 156
2019
Q4
$15K Hold
75
﹤0.01% 161
2019
Q3
$13K Hold
75
﹤0.01% 150
2019
Q2
$13K Hold
75
﹤0.01% 143
2019
Q1
$14K Hold
75
﹤0.01% 141
2018
Q4
$12K Buy
+75
New +$12.7K ﹤0.01% 145

Other funds holding ISRG

Salomon & Ludwin's ISRG Position: Q2 2026 in Review

Salomon & Ludwin reduced its Intuitive Surgical (ISRG) stake by 40% in Q2 2026, selling an estimated $44.6K and leaving 151 shares worth $60.8K. The position accounts for 0.01% of the portfolio, ranked #460.

Salomon & Ludwin first reported a position in ISRG in Q4 2018 and has held it in 18 quarters since. The position peaked at $127K in Q4 2025. 2,254 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Salomon & Ludwin held 151 shares of Intuitive Surgical worth $60.8K as of Q2 2026.
  • Salomon & Ludwin sold 102 Intuitive Surgical shares in Q2 2026, an estimated $44.6K.
  • Intuitive Surgical made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #460 holding.
  • Salomon & Ludwin first reported a position in Intuitive Surgical in Q4 2018 and has held it in 18 quarters since.
  • Salomon & Ludwin's Intuitive Surgical position peaked at $127K in Q4 2025.
  • 2,254 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.